• 1
    Ferlay J,Bray F,Pisani P,Parkin DM. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC Cancer Base No. 5., Lyon: IARC, 2001.
  • 2
    Llovet JM,Burroughs A,Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 190717.
  • 3
    Bosch FX,Ribes J,Diaz M,Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: S516.
  • 4
    Sonoda H,Inoue H,Ogawa K,Utsunomiya T,Masuda TA,Mori M. Significance of skp2 expression in primary breast cancer. Clin Cancer Res 2006; 12: 121520.
  • 5
    Masuda TA,Inoue H,Nishida K,Sonoda H,Yoshikawa Y,Kakeji Y,Utsunomiya T,Mori M. Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma. Clin Cancer Res 2003; 9: 56938.
  • 6
    Masuda TA,Inoue H,Sonoda H,Mine S,Yoshikawa Y,Nakayama K,Nakayama K,Mori M. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res 2002; 62: 381925.
  • 7
    Rape M,Kirschner MW. Autonomous regulation of the anaphase-promoting complex couples mitosis to S-phase entry. Nature 2004; 432: 58895.
  • 8
    Lukas J,Bartek J. Cell division: the heart of the cycle. Nature 2004; 432: 5647.
  • 9
    Welsh JB,Zarrinkar PP,Sapinoso LM,Kern SG,Behling CA,Monk BJ,Lockhart DJ,Burger RA,Hampton GM. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci USA 2001; 98: 117681.
  • 10
    LaTulippe E,Satagopan J,Smith A,Scher H,Scardino P,Reuter V,Gerald WL. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res 2002; 62: 4499506.
  • 11
    Okamoto Y,Ozaki T,Miyazaki K,Aoyama M,Miyazaki M,Nakagawara A. UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme. Cancer Res 2003; 63: 416773.
  • 12
    Wagner KW,Sapinoso LM,El-Rifai W,Frierson HF,Butz N,Mestan J,Hofmann F,Deveraux QL,Hampton GM. Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin. Oncogene 2004; 23: 66219.
  • 13
    Pallante P,Berlingieri MT,Troncone G,Kruhoffer M,Orntoft TF,Viglietto G,Caleo A,Migliaccio I,Decaussin-Petrucci M,Santoro M,Palombini L,Fusco A. UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas. Br J Cancer 2005; 93: 46471.
  • 14
    Mori M,Mimori K,Yoshikawa Y,Shibuta K,Utsunomiya T,Sadanaga N,Tanaka F,Matsuyama A,Inoue H,Sugimachi K. Analysis of the gene-expression profile regarding the progression of human gastric carcinoma. Surgery 2002; 131: S3947.
  • 15
    Nishida K,Mine S,Utsunomiya T,Inoue H,Okamoto M,Udagawa H,Hanai T,Mori M. Global analysis of altered gene expressions during the process of esophageal squamous cell carcinogenesis in the rat: a study combined with a laser microdissection and a cDNA microarray. Cancer Res 2005; 65: 4019.
  • 16
    Quackenbush J. Microarray data normalization and transformation. Nat Genet 2002; 32: 496501.
  • 17
    Ogawa K,Utsunomiya T,Mimori K,Tanaka F,Inoue H,Nagahara H,Murayama S,Mori M. Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. Clin Cancer Res 2005; 11: 288993.
  • 18
    Ieta K,Tanaka F,Utsunomiya T,Kuwano H,Mori M. CEACAM6 gene expression in intrahepatic cholangiocarcinoma. Br J Cancer 2006; 95: 53240.
  • 19
    Lee CG,Ren J,Cheong IS,Ban KH,Ooi LL,Yong Tan S,Kan A,Nuchprayoon I,Jin R,Lee KH,Choti M,Lee LA. Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene 2003; 22: 2592603.
  • 20
    Filmus J,Selleck SB. Glypicans: proteoglycans with a surprise. J Clin Invest 2001; 108: 497501.
  • 21
    Bernfield M,Gotte M,Park PW,Reizes O,Fitzgerald ML,Lincecum J,Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999; 68: 72977.
  • 22
    Filmus J,Church JG,Buick RN. Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine. Mol Cell Biol 1988; 8: 42439.
  • 23
    Hsu HC,Cheng W,Lai PL. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution. Cancer Res 1997; 57: 517984.
  • 24
    Zhu ZW,Friess H,Wang L,Abou-Shady M,Zimmermann A,Lander AD,Korc M,Kleeff J,Buchler MW. Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders. Gut 2001; 48: 55864.
  • 25
    Capurro M,Wanless IR,Sherman M,Deboer G,Shi W,Miyoshi E,Filmus J. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003; 125: 8997.
  • 26
    Koide N,Hada H,Shinji T,Ujike K,Hirasaki S,Yumoto Y,Hanafusa T,Kadomatsu K,Muramatsu H,Muramatsu T,Tsuji T. Expression of the midkine gene in human hepatocellular carcinomas. Hepatogastroenterology 1999; 46: 318996.
  • 27
    Ikematsu S,Yano A,Aridome K,Kikuchi M,Kumai H,Nagano H,Okamoto K,Oda M,Sakuma S,Aikou T,Muramatsu H,Kadomatsu K, et al. Serum midkine levels are increased in patients with various types of carcinomas. Br J Cancer 2000; 83: 7016.
  • 28
    Ohuchida T,Okamoto K,Akahane K,Higure A,Todoroki H,Abe Y,Kikuchi M,Ikematsu S,Muramatsu T,Itoh H. Midkine protects hepatocellular carcinoma cells against TRAIL-mediated apoptosis through down-regulation of caspase-3 activity. Cancer 2004; 100: 24306.
  • 29
    Bredel M,Bredel C,Juric D,Harsh GR,Vogel H,Recht LD,Sikic BI. Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res 2005; 65: 867989.
  • 30
    Wilting SM,Snijders PJ,Meijer GA,Ylstra B,van den Ijssel PR,Snijders AM,Albertson DG,Coffa J,Schouten JP,van de Wiel MA,Meijer CJ,Steenbergen RD. Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol 2006; 209: 22030.
  • 31
    Townsley FM,Aristarkhov A,Beck SHershko A,Ruderman JV. Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase. Proc Natl Acad Sci USA 1997; 94: 23627.
  • 32
    Salvesen GS,Dixit VM. Caspases: intracellular signaling by proteolysis. Cell 1997; 91: 4436.
  • 33
    Takahashi Y,Ishii Y,Nishida Y,Ikarashi M,Nagata T,Nakamura T,Yamamori S,Asai S. Detection of aberrations of ubiquitin-conjugating enzyme E2C gene (UBE2C) in advanced colon cancer with liver metastases by DNA microarray and two-color FISH. Cancer Genet Cytogenet 2006; 168: 305.
  • 34
    El-Rifai W,Frierson HF,Jr,Moskaluk CA,Harper JC,Petroni GR,Bissonette EA,Jones DR,Knuutila S,Powell SM. Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa. Gastroenterology 2001; 121: 5928.
  • 35
    Tsafrir D,Bacolod M,Selvanayagam Z,Tsafrir I,Shia J,Zeng Z,Liu H,Krier C,Stengel RF,Barany F,Gerald WL,Paty PB et al. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 2006; 66: 212937.
  • 36
    Fujita Y,Sakakura C,Shimomura K,Nakanishi M,Yasuoka R,Aragane H,Hagiwara A,Abe T,Inazawa J,Yamagishi H. Chromosome arm 20q gains and other genomic alterations in esophageal squamous cell carcinoma, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Hepatogastroenterology 2003; 50: 185763.
  • 37
    Fukushige S,Waldman FM,Kimura M,Abe T,Furukawa T,Sunamura M,Kobari M,Horii A. Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosomes Cancer 1997; 19: 1619.
  • 38
    Wong N,Lai P,Lee SW,Fan S,Pang E,Liew CT,Sheng Z,Lau JW,Johnson PJ. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. Am J Pathol 1999; 154: 3743.